# Gladstone Commercial Corp: financial statements, quarterly

GOOD · Nasdaq · CIK 1234006 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/good.md) · [Financials](/companies/good/financials.md) · [Filings](/companies/good/filings.md) · [Insiders](/companies/good/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/good/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [36.5](/filings/0001234006-24-000015.md) | [35.9 d](/filings/0001234006-26-000005.md) | [35.7](/filings/0001234006-25-000007.md) | [37.1](/filings/0001234006-25-000015.md) | [39.2](/filings/0001234006-25-000022.md) | [37.4 d](/filings/0001234006-26-000005.md) | [37.5](/filings/0001234006-26-000012.md) | [39.5](/filings/0001234006-26-000018.md) | [40.8](/filings/0001234006-25-000022.md) | [43.5 d](/filings/0001234006-26-000005.md) | [41.9](/filings/0001234006-26-000012.md) | [44.0](/filings/0001234006-26-000018.md) |
| Interest expense | $m | [9.9](/filings/0001234006-23-000015.md) | [9.5 d](/filings/0001234006-24-000003.md) | [9.5](/filings/0001234006-24-000007.md) | [9.5](/filings/0001234006-25-000015.md) | [9.3](/filings/0001234006-25-000022.md) | [9.1 d](/filings/0001234006-26-000005.md) | [9.1](/filings/0001234006-26-000012.md) | [10.1](/filings/0001234006-26-000018.md) | [10.7](/filings/0001234006-25-000022.md) | [12.0 d](/filings/0001234006-26-000005.md) | [11.5](/filings/0001234006-26-000012.md) | [11.4](/filings/0001234006-26-000018.md) |
| Net income | $m | [1.8](/filings/0001234006-24-000015.md) | [4.5 d](/filings/0001234006-26-000005.md) | [3.5](/filings/0001234006-25-000007.md) | [1.6](/filings/0001234006-25-000015.md) | [11.7](/filings/0001234006-25-000022.md) | [7.2 d](/filings/0001234006-26-000005.md) | [5.1](/filings/0001234006-26-000012.md) | [4.6](/filings/0001234006-26-000018.md) | [4.1](/filings/0001234006-25-000022.md) | [5.4 d](/filings/0001234006-26-000005.md) | [7.0](/filings/0001234006-26-000012.md) | [8.3](/filings/0001234006-26-000018.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0001234006-24-000015.md) | not reported | [0.01](/filings/0001234006-25-000007.md) | [(0.04)](/filings/0001234006-25-000015.md) | [0.20](/filings/0001234006-25-000022.md) | not reported | [0.04](/filings/0001234006-26-000012.md) | [0.03](/filings/0001234006-26-000018.md) | [0.02](/filings/0001234006-25-000022.md) | not reported | [0.08](/filings/0001234006-26-000012.md) | [0.11](/filings/0001234006-26-000018.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0001234006-24-000015.md) | not reported | [0.01](/filings/0001234006-25-000007.md) | [(0.04)](/filings/0001234006-25-000015.md) | [0.20](/filings/0001234006-25-000022.md) | not reported | [0.04](/filings/0001234006-26-000012.md) | [0.03](/filings/0001234006-26-000018.md) | [0.02](/filings/0001234006-25-000022.md) | not reported | [0.08](/filings/0001234006-26-000012.md) | [0.11](/filings/0001234006-26-000018.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [18.3](/filings/0001234006-24-000015.md) | [12.0](/filings/0001234006-26-000005.md) | [10.5](/filings/0001234006-25-000007.md) | [10.4](/filings/0001234006-25-000015.md) | [10.5](/filings/0001234006-25-000022.md) | [11.0](/filings/0001234006-26-000005.md) | [10.4](/filings/0001234006-26-000012.md) | [11.7](/filings/0001234006-26-000018.md) | [18.4](/filings/0001234006-25-000022.md) | [10.8](/filings/0001234006-26-000018.md) | [8.0](/filings/0001234006-26-000012.md) | [10.4](/filings/0001234006-26-000018.md) |
| Total assets | $m | [1,167](/filings/0001234006-23-000015.md) | [1,133](/filings/0001234006-25-000003.md) | [1,105](/filings/0001234006-24-000007.md) | [1,106](/filings/0001234006-24-000011.md) | [1,096](/filings/0001234006-24-000015.md) | [1,094](/filings/0001234006-26-000005.md) | [1,160](/filings/0001234006-25-000007.md) | [1,210](/filings/0001234006-25-000015.md) | [1,265](/filings/0001234006-25-000022.md) | [1,247](/filings/0001234006-26-000018.md) | [1,231](/filings/0001234006-26-000012.md) | [1,243](/filings/0001234006-26-000018.md) |
| Total liabilities | $m | [821](/filings/0001234006-23-000015.md) | [809](/filings/0001234006-25-000003.md) | [787](/filings/0001234006-24-000007.md) | [790](/filings/0001234006-24-000011.md) | [757](/filings/0001234006-24-000015.md) | [753](/filings/0001234006-26-000005.md) | [807](/filings/0001234006-25-000007.md) | [863](/filings/0001234006-25-000015.md) | [910](/filings/0001234006-25-000022.md) | [905](/filings/0001234006-26-000018.md) | [897](/filings/0001234006-26-000012.md) | [915](/filings/0001234006-26-000018.md) |
| Long-term debt | $m | [749](/filings/0001234006-23-000015.md) | [739](/filings/0001234006-25-000003.md) | [719](/filings/0001234006-24-000007.md) | [723](/filings/0001234006-24-000011.md) | [693](/filings/0001234006-24-000015.md) | [693](/filings/0001234006-26-000005.md) | [741](/filings/0001234006-25-000007.md) | [794](/filings/0001234006-25-000015.md) | [843](/filings/0001234006-25-000022.md) | [843](/filings/0001234006-26-000018.md) | [836](/filings/0001234006-26-000012.md) | [852](/filings/0001234006-26-000018.md) |
| Shareholders' equity | $m | [175](/filings/0001234006-23-000015.md) | [153](/filings/0001234006-25-000003.md) | [147](/filings/0001234006-24-000007.md) | [146](/filings/0001234006-24-000011.md) | [169](/filings/0001234006-24-000015.md) | [171](/filings/0001234006-26-000005.md) | [183](/filings/0001234006-25-000007.md) | [177](/filings/0001234006-25-000015.md) | [185](/filings/0001234006-25-000022.md) | [172](/filings/0001234006-26-000018.md) | [163](/filings/0001234006-26-000012.md) | [157](/filings/0001234006-26-000018.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [17.8 d](/filings/0001234006-24-000015.md) | [11.9 d](/filings/0001234006-26-000005.md) | [15.0](/filings/0001234006-25-000007.md) | [13.6 d](/filings/0001234006-25-000015.md) | [5.5 d](/filings/0001234006-25-000022.md) | [22.8 d](/filings/0001234006-26-000005.md) | [17.7](/filings/0001234006-26-000012.md) | [35.8 d](/filings/0001234006-26-000018.md) | [18.9 d](/filings/0001234006-25-000022.md) | [15.7 d](/filings/0001234006-26-000005.md) | [17.9](/filings/0001234006-26-000012.md) | [17.6 d](/filings/0001234006-26-000018.md) |
| Dividends paid | $m | [15.2 d](/filings/0001234006-24-000015.md) | [15.2 d](/filings/0001234006-26-000005.md) | [15.2](/filings/0001234006-25-000007.md) | [15.3 d](/filings/0001234006-25-000015.md) | [16.1 d](/filings/0001234006-25-000022.md) | [16.3 d](/filings/0001234006-26-000005.md) | [16.5](/filings/0001234006-26-000012.md) | [16.9 d](/filings/0001234006-26-000018.md) | [17.1 d](/filings/0001234006-25-000022.md) | [17.6 d](/filings/0001234006-26-000005.md) | [17.6](/filings/0001234006-26-000012.md) | [17.6 d](/filings/0001234006-26-000018.md) |
| Share repurchases | $m | [0.0 d](/filings/0001234006-24-000015.md) | [0.0 d](/filings/0001234006-26-000005.md) | not reported | not reported | [0.0 d](/filings/0001234006-24-000015.md) | [0.0 d](/filings/0001234006-26-000005.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [39.5](/filings/0001234006-23-000015.md) | [39.9](/filings/0001234006-24-000007.md) | [40.0](/filings/0001234006-24-000011.md) | [39.9](/filings/0001234006-24-000015.md) | [40.0](/filings/0001234006-25-000007.md) | [40.3](/filings/0001234006-25-000015.md) | [42.8](/filings/0001234006-25-000022.md) | [44.6](/filings/0001234006-26-000012.md) | [46.2](/filings/0001234006-26-000018.md) | [46.9](/filings/0001234006-25-000022.md) | [48.4](/filings/0001234006-26-000012.md) | [48.4](/filings/0001234006-26-000018.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 48,407,501 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0001234006-26-000018.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.